HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myostatin inhibition: a new treatment for androgen deprivation-induced sarcopenia?

AuthorsMathis Grossmann
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 99 Issue 10 Pg. 3625-8 (Oct 2014) ISSN: 1945-7197 [Electronic] United States
PMID25279574 (Publication Type: Editorial, Research Support, Non-U.S. Gov't, Comment)
Chemical References
  • AMG 745
  • Androgen Antagonists
  • Immunoglobulin Fc Fragments
  • MSTN protein, human
  • Myostatin
  • Recombinant Fusion Proteins
Topics
  • Androgen Antagonists (adverse effects)
  • Body Mass Index
  • Humans
  • Immunoglobulin Fc Fragments (adverse effects)
  • Male
  • Muscle, Skeletal (drug effects)
  • Myostatin (antagonists & inhibitors)
  • Prostatic Neoplasms (drug therapy)
  • Recombinant Fusion Proteins (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: